Elevate your enterprise data technology and strategy at Transform 2021.

India’s Perfint, medical-device co., raises $3.5M — Perfint, a Chennai, India-based producer of medical equipment, raised $3.5 million in a new funding round.

IDG Ventures India and Erasmus Venture Fund provided the cash. IDG supplied the bulk of the investment — $3 million — with Erasmus providing the rest.

Perfint’s first product, the PIGA-CT, is a tool positioner for minimally invasive procedures. The PIGA-CT is designed to work with a variety of compact CT scanners for image-guided positioning.

Source MDx strikes Pfizer partnership to ID cancer, inflammation “fingerprints” — Source MDx, a Boulder, Colo., developer of molecular diagnostics, struck a multi-year partnership with Pfizer. The two companies will identify and validate “biomarkers” — essentially, any sort of biochemical signal, such as levels of a particular protein or RNA snippet — that can be used to track the effect of a drug or predict the course of disease.

The collaboration will focus on Pfizer’s cancer and inflammation drug-development programs. Financial details weren’t disclosed, although Pfizer will make an equity investment in Source MDx and pay both a technology licensing fee and R&D costs. Source MDx will retain commercial rights to diagnostic biomarkers discovered and validated by the partnership.


VentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative technology and transact. Our site delivers essential information on data technologies and strategies to guide you as you lead your organizations. We invite you to become a member of our community, to access:
  • up-to-date information on the subjects of interest to you
  • our newsletters
  • gated thought-leader content and discounted access to our prized events, such as Transform 2021: Learn More
  • networking features, and more
Become a member